Audit Findings. Vendor shall implement any required safeguards as identified by Citizens or by any audit of Vendor’s privacy and security controls.
Audit Findings. Contractor shall implement reasonably required safeguards as identified by City or by any audit of Contractor’s data privacy and information security program.
Audit Findings. 6.1 The auditor will present the audit findings along with:
a) supporting documentation;
b) preliminary estimation of the audit findings.
6.2 If the audited party fails to cooperate or does not provide adequate documentation, the auditor may:
a) request additional information;
b) request additional validation tests;
c) request additional client site visits;
d) impose further sanctions pursuant to section 16 of the terms and conditions.
6.3 The auditor and the audited party should work together in good faith to resolve any differences in opinion arising from the audit.
Audit Findings. If an audit results in findings of non-compliance, Nearmap may, at its discretion (a) invoice any additional license fees due based on the standard Nearmap fees in place at the time of the original licence grant, (b) recover the reasonable cost of the audit if additional fees exceed five (5) per cent of the Fees paid during the audit period and (c) terminate this Agreement in accordance with clause 6.2. Licensee must pay all invoices issued under this clause within thirty (30) days following the date of invoice.
Audit Findings. Contractor shall implement at its sole expense any remedial actions as identified by the City as a result of the audit.
Audit Findings. As the State Administrative Authority (SAA), Ohio EMA takes seriously the responsibility of administering the grant funds we are entrusted with from DHS/FEMA. This guidance refers to the Super Circular (2 CFR Part 200) and the requirements therein. Subrecipients (regional fiscal agents) should refer to the Super Circular and ensure they are meeting all requirements set forth therein. In addition, all requirements set forth in this guidance are passed along to subrecipients (Regional Fiscal Agents). By signing the grant agreement, subrecipients (Regional Fiscal Agent) agree to be bound by all requirements set forth in this guidance, the grant agreement, and the Super Circular. As a result, any audit findings that occur with respect to improper procurement or from not abiding by the requirements set forth in this guidance will be the responsibility of the subrecipient (Regional Fiscal Agent). Ohio EMA will assume no financial responsibility for said audit findings, and if forced to pay on behalf of the subrecipient (Regional Fiscal Agent) will take all action necessary to recover those costs.
Audit Findings. 18.2.1 ZMC shall provide WuXi a copy of the audit report within thirty (30) calendar days of completion of an audit. After delivery of the audit report, WuXi shall provide ZMC with a written response to such report within thirty (30) calendar days from WuXi’s receipt of the report from ZMC. All information in the audit report and subsequent follow up is considered confidential information between both Parties.
Audit Findings. Should the Accountant believe there is an inaccuracy in any of the Licensee’s payments or noncompliance by the Licensee with any of such terms and conditions, the Accountant will have the right to make and retain copies (including photocopies) of any pertinent portions of the records and books of account. In the event that Licensee's royalties calculated for any quarterly period are underreported by more than Five Percent (5%), the costs of any audit and review initiated by University will be borne by Licensee; otherwise, University will bear the costs of any audit initiated by University.
Audit Findings. 14.2.2.1 At COMPANY’s or AMGEN’s request, an exit meeting shall be held with COMPANY and its representatives and AMGEN and its representatives to discuss audit findings, if any. COMPANY shall provide AMGEN with a copy of the audit report within thirty (30) calendar days upon completion of the audit. For those findings that AMGEN determines in good faith may materially affect AMGEN’s ability to perform the Services, AMGEN shall issue a written response to COMPANY’s report within thirty (30) days of AMGEN’s receipt of such report. AMGEN’s response shall identify the timelines and approach for addressing COMPANY’s findings.
14.3 Regulatory Agency Inspections
14.3.1 COMPANY shall notify AMGEN within twenty-four (24) hours upon notification by any Regulatory Authority of any intended inspection of AMGEN’s facilities or records relating to the manufacturing, testing, and storage of the Product.
14.3.2 AMGEN will be solely responsible for hosting and managing regulatory inspections at its facilities.
14.3.3 COMPANY will have the right to review and comment on AMGEN’s proposed response to observations raised by the Regulatory Authorities relating to the Product and AMGEN shall consider such comments in good faith. AMGEN shall provide COMPANY with a copy of the final response after submission to any Regulatory Authorities.
Audit Findings. 14.2.2.1 At COMPANY’s or AMGEN’s request, an exit meeting shall be held with COMPANY and its representatives and AMGEN and its representatives to discuss audit findings, if any. COMPANY shall provide AMGEN with a copy of the audit report within thirty (30) calendar days upon completion of the audit. For those findings that AMGEN determines in good faith may materially affect AMGEN’s ability to perform the Services, AMGEN shall issue a written response to COMPANY’s report within thirty (30) days of AMGEN’s receipt of such report. AMGEN’s response shall identify the timelines and approach for addressing COMPANY’s findings.
14.3 Regulatory Agency Inspections
14.3.1 COMPANY shall notify AMGEN within twenty-four (24) hours upon notification by any Regulatory Authority of any intended inspection of AMGEN’s facilities or records relating to the manufacturing, testing, and storage of the Product. [*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.
14.3.2 AMGEN will be solely responsible for hosting and managing regulatory inspections at its facilities.
14.3.3 COMPANY will have the right to review and comment on AMGEN’s proposed response to observations raised by the Regulatory Authorities relating to the Product and AMGEN shall consider such comments in good faith. AMGEN shall provide COMPANY with a copy of the final response after submission to any Regulatory Authorities.
14.3.4 AMGEN will inform COMPANY of any critical Regulatory Authority inspection observations not directly relevant to the Product where it can reasonably be assumed the observation impacts upon the Services or Product provided to COMPANY.
